Caliope Gialousis
Family · Youngstown, OHNPI 1376271544
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 121 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Mayne Pharma Commercial LLC at 34.8% of the total. 2025 is the largest year on record at $828, 4.0 times the $209 reported in 2022.
Across 121 payments — averaging $17.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mayne Pharma Commercial LLC$756
- Sumitomo Pharma America, Inc.$278
- Sage Therapeutics, LLC$237
- AbbVie$191
- Astellas Pharma US Inc$116
- Exeltis, USA Inc.$92
- plus $502 from 13 others
What the payments were for
- Food & beverage$2,172100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mayne Pharma Commercial LLC | 45 | $756 |
| Sumitomo Pharma America, Inc. | 14 | $278 |
| Sage Therapeutics, LLC | 16 | $237 |
| AbbVie | 9 | $191 |
| Astellas Pharma US Inc | 6 | $116 |
| Exeltis, USA Inc. | 6 | $92 |
| Optumhealth Care Solutions, LLC | 4 | $75 |
| Bayer | 3 | $67 |
| Agile Therapeutics, Inc. | 3 | $54 |
| Dexcom, Inc. | 1 | $47 |
| Supernus Pharmaceuticals, Inc. | 2 | $46 |
| Mylan Pharmaceuticals Inc. | 2 | $38 |
| Shield Therapeutics Inc | 2 | $37 |
| Myovant Sciences Inc. | 2 | $36 |
| Organon | 2 | $35 |
| Hologic Sales And Service, LLC | 1 | $20 |
| Gilead | 1 | $19 |
| Pfizer | 1 | $16 |
| Evofem Biosciences, Inc. | 1 | $13 |
How this compares
$2,172 in reported general payments places this provider in the 80th percentile of 6,812 family providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluconazole | 12 | $37 |
Paid to pharmacies, not to this prescriber.
Other family in Youngstown
- Andrea SvobodaYoungstown$91K
- Leigh Ann PanschDayton$670K
- Natalie BelliniMayfield Heights$582K
- Kaitlyn LovettMontgomery$286K
- Amy RossDayton$281K
- Renee OttSandusky$179K
- Megan MillerSpringfield$156K
- George KnightCincinnati$130K
- Jillian HuntCincinnati$116K
- Florence StewartNew Albany$113K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.